Search Results
Results found for "David M. Thal"
- 📰 GPCR Weekly News, November 20 to 26, 2023
David Gloriam and his team present GproteinDb in 2024 Are you looking to hire?
- Ode to GPCRs
Physiology or Medicine was awarded jointly to Ragnar Arthur Granit, Haldan Keffer Hartline, and George David Shampo, M. A. & Kyle, R. A. Sir Bernard Katz--winner of Nobel Prize in physiology or medicine. Ekaterini Tiligada, C., Tiligada, E. & Ennis, M.
- 📰 GPCR Weekly News, March 11 to 17, 2024
This week's highlight includes congrats to: Makaía M Papasergi-Scott, Peter Gmeiner, Brian K Kobilka,
- 📰 GPCR Weekly News, May 8 to 14, 2023
Continuing Study Addex Therapeutics in the 23rd BioEquity Europe Conference Simon Bekker-Jensen and Mette M
- 📰 GPCR Weekly News, February 5 to 11, 2024
Magdalena M Scharf, Antonella Di Pizio, Ines Liebscher, Hannes Schihada, and Gunnar Schulte et al. on
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Devki D Sukhtankar and Pina M Cardarelli's research: Burixafor Hydrobromide (GPC-100) effects on hematopoietic
- 📰 GPCR Weekly News, January 8 to 14, 2024
Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in
- VAMP2: a crucial player in the delivery of MOR to the synapse
K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T. Kavalali. 2001.
- 📰 GPCR Weekly News, May 27 to June 2, 2024
Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290 Crinetics Pharmaceuticals Appoints Robert M.
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
José Labandeira-García , Rafael Franco Endomembrane GPCR signaling: 15 years on, the quest continues Davide
- 📰 GPCR Weekly News, February 12 to 18, 2024
Greetings, avid readers! Nayara Braga Emidio, Ross Cheloha, Laura M Wingler, et al. for their work on Nanobody-Mediated Dualsteric
- Odorant receptors – a bit of smell for drug discovery
is quite stable, the number of ORs expressed in different human tissues is highly variable from more than genito-urinary system, the activation of ORs was shown to influence the motility of spermatozoa (Spehr M.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Working closely with Professor David Parker of Durham University, Trinquet’s group cracked the scaffold
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Maziarz, M., et al., Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
a GPCR Paper with his team: Targeted Drug Design through GPCR Mutagenesis: Insights from β2AR China M
- 📰 GPCR Weekly News, April 8 to 14, 2024
insights into G protein coupling specificity at a class A GPCR Jianjun Cao, Arthur Christopoulos, Patrick M.
- Overview of adhesion GPCRs self-activation
highlighted a new hydrophobic conserved motif composed of phenylalanine (F)/leucine (L) and methionine (M) each G protein with the receptor showed that there are more polar interactions in Gq/Gs engagements than
- Quantifying Receptor Selectivity in Modern Drug Discovery
Another produces a larger shift in EC₅₀ in one system than another, and we assume we’ve found therapeutic It prevents discovery teams from advancing compounds based on artifacts of expression systems rather than A development decision may hinge on assay sensitivity rather than molecular behavior. practical solution: use a potency metric that incorporates both efficacy and EC₅₀ (log maximal response divided Strategic Implications for Drug Hunters Quantifying receptor selectivity correctly does more than refine
- From Failed Experiments to Predictive GPCR Models
Rather than focusing solely on explaining receptor behavior post hoc, his group began developing workflows Carlsson notes that it’s easier to find pharmacologists to run assays than it is to persuade chemists former students now work in industry, where their ability to bridge the computational-experimental divide
- Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
GPCRs are divided into six classes based on amino acid sequence similarities, but only four of the classes
- Structural basis of adhesion GPCR GPR110 activation by stalk peptide and G-proteins coupling
Gq, Gs, Gi, G12 and G13 engagements with GPR110 reveals details of G-protein engagement, including a dividing
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
These receptors have much larger binding pockets than the majority of GPCRs that have been successfully ’ interaction ensures that all molecules in the library are specific for the target receptor rather than either G protein signaling or arrestin signaling, and superagonists with signaling activity higher than Orion’s CCR2 antagonist analog (OB-004), discovered in only 6 months, is considerably more potent than Library-based screening methodology for engineering small protein GPCR ligands Paolini-Bertrand, M.
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
robustly both in the peripheral nervous system and in central circuits like the prefrontal cortex and thalamus despite these targets falling short clinically: “The downstream cascade is probably a little bit weaker than hitting a GPCR... and honestly, like with the trials, they were not really that sufficiently better than
- On-cell nuclear magnetic resonance spectroscopy to probe cell surface interactions
This may be broadly divided into studies focused on obtaining detailed molecular information in the intracellular
- Dr. GPCR and Eurofins DiscoverX Join Forces to Accelerate GPCR Drug Discovery
Drawing on more than 25 years of GPCR expertise, Eurofins DiscoverX delivers one of the industry’s most “They offer more than assays—they build true scientific partnerships that help teams get the most from With more than 25 years of expertise and coverage of over 90% of the human GPCRome, Eurofins DiscoverX
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
With street-level contamination rising faster than medicine can adapt, Catherine’s work shows why overdose A Crisis That’s Redefining Overdose In 2023, more than 107,000 Americans died from drug overdoses , the The insight is simple but urgent: the drug supply evolves faster than medicine. The Urgency Ahead Every overdose today is more complicated than the last. And the illicit supply is moving faster than clinical medicine can adjust.
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
Her story is about more than experiments or data points. Rather than treating opioid pharmacology as a purely theoretical exercise, she collaborates with harm-reduction Academic success is less about prestige than about impact. That urgency, more than titles, positions, or prestige, is what sustains a lasting career in science. Catherine’s story shows that when purpose drives research, science becomes more than a job—it becomes
- How Early Strategic Decision Making Creates Alignment and Better Results
But that is exactly why they matter more than we think. ever wondered why effort does not always translate into results, the answer often lives much earlier than 👉 Milestones, progress signals, and success criteria are often assumed rather than agreed upon. Tradeoffs feel intentional rather than painful. has room to shape behavior rather than react to it.
- Why Fundraising Mistakes Kill Strong Biotech Startups
Milestones are chosen for narrative strength rather than strategic leverage. recent round, this is an opportunity to recognize where pressure may already be shaping decisions more than Milestones are selected for narrative clarity rather than strategic necessity. What helps the raise starts to matter more than what strengthens the company. 👉 In practice, biotech quality under pressure. 👉 As fundraising intensity increases, they slow down decision-making rather than
- How GPCR Collaboration Built an Innovation Engine
Rather than carving out turf, they grew by designing around collective capacity . environment lowers friction between these specialties, making innovation structurally inevitable rather than The structure you train in often matters more than the experiment you start with. Weekly seminars were mandatory but lightweight, designed to connect rather than perform.














